RSS   Newsletter   Contact   Advertise with us
Post Online Media
Post Online Media Magazine

NeoPhore appoints Matthew Baker as vice president

Share on Twitter Share on LinkedIn
Christian Fernsby | Cambridge, United Kingdom |
Matthew BakerNeoPhore Limited, a small molecule cancer immuno-oncology company, announced the appointment of Matthew Baker as VP Immunology to the company's management team.
Dr. Baker has more than 15 years' experience developing biologics in biotech and pharma companies and is a research expert in B and T cell immunology, including drug immunogenicity.

Dr. Baker has held entrepreneurial and leadership positions across the biotechnology industry including Chief Scientific Officer of Abzena plc and co-founder, Chief Scientific Officer of Denceptor Therapeutics.

Dr. Baker has more than 15 years' experience developing biologics in biotech and pharma companies and is a research expert in B and T cell immunology, including drug immunogenicity.

Prior to this he was co-founder, Chief Executive Officer and Chief Scientific Officer of Antitope Ltd Dr. Baker has more than 15 years' experience developing biologics in biotech and pharma companies and is a research expert in B and T cell immunology, including drug immunogenicity.

Dr. Baker is currently Non-Executive Director at Oxford Genetics Ltd.


 LATEST MOVES FROM United Kingdom 


POST Online Media Contact